Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Merck

Dow Jones Rallies; Mark Zuckerberg Says This As Facebook Parent Meta Surges; Apple Earnings Beat

The Dow Jones rose as the market rallied. Mark Zuckerberg was bullish as Facebook parent Meta Platforms surged on results. Apple earnings beat views while three stocks eye buy points.

Investors Business Daily

Stock Market Up Despite GDP Decline; Facebook, PayPal Gain On Earnings

Stock Market Up Despite GDP Decline; Facebook, PayPal Gain On Earnings

The stock market gained as Facebook and PayPal rose on earnings, in spite of GDP falling.

Investors Business Daily

Here We Go Again: Stock Market Indexes Fade; Meta Platforms Soars, But GDP Falls In Q1

Here We Go Again: Stock Market Indexes Fade; Meta Platforms Soars, But GDP Falls In Q1

While earnings were mainly higher, the U.S. economy shrank in the first quarter.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

IBD Stock Of The Day Merck Notches Quarterly Beat As Covid Pill Brings In $3.2 Billion

Merck reported better-than-expected first-quarter sales and earnings, helped by its Covid pill. In response, Merck stock rose Thursday.

Investors Business Daily

Merck Clocks 50% Q1 Sales Growth Boosted By COVID-19 Treatment, Tightens FY22 EPS Outlook

Merck & Co Inc's (NYSE:MRK) Q1 sales reached $15.90 billion, +50% Y/Y, beating the consensus of $14.68 billion. Excluding the foreign exchange impact, revenues were up 52%. Pharmaceutical sales increased 53% to $14.11 billion, primarily driven by molnupiravir, oncology, vaccines, and hospital acute care products. Pharmaceutical sales growth, excluding Lagevrio sales, was…

Merck Stock Gains As Covid, Keytruda Sales Help Q1 Earnings Beat, Profit Forecast Boost

“We successfully delivered across our key strategic priorities and achieved strong top- and bottom-line growth,” said CEO Robert Davis.

Few Stocks With Rising Profit Estimates Also Show Good Chart Patterns

Analysts expect Merck to grow EPS 37% to $1.83 a share when it announces results Thursday morning.

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

EXPLAINER: COVID-19 pills must be taken within 5 days

EXPLAINER: COVID-19 pills must be taken within 5 days

COVID-19 patients have two treatment options that can be taken at home

The Independent UK

Dow Jones Futures Fall As Market Rally Weakens; Tesla Shanghai Tries To Reopen, Twitter Pops

Dow Jones Futures Fall As Market Rally Weakens; Tesla Shanghai Tries To Reopen, Twitter Pops

The market rally is ailing, but not all areas. Tesla Shanghai is working to reopen with earnings due. Twitter stock popped.

Investors Business Daily

Dow Jones Futures Rise After Market Rally; Elon Musk Offers To Buy Twitter

Dow Jones Futures Rise After Market Rally; Elon Musk Offers To Buy Twitter

The market rebounded, but curb your enthusiasm. Apple, Fortinet, Marriott lead 7 stocks near buy points.

Investors Business Daily

Dow Jones Rallies; New Warren Buffett Stock Explodes; Tesla Gains Amid Cyber Rodeo

Dow Jones Rallies; New Warren Buffett Stock Explodes; Tesla Gains Amid Cyber Rodeo

The Dow Jones rallied as the stock market tried to find its footing. A Warren Buffett stock shot up while Tesla stock raced into the green.

Investors Business Daily

Merck Projects $10 Billion From Its Next Blockbuster Segment; Will It Measure Up?

Merck Projects $10 Billion From Its Next Blockbuster Segment; Will It Measure Up?

Merck stock popped to a six-month high Tuesday after the firm projected $10 billion in peak revenue from its cardiovascular drugs.

Investors Business Daily

Merck Expands Elkton Manufacturing Facility To Boost HPV Vaccine Supply

Merck Expands Elkton Manufacturing Facility To Boost HPV Vaccine Supply

Merck & Co Inc (NYSE: MRK) has invested in manufacturing and recently expanded its vaccines manufacturing facility in Elkton, VA.

Merck - Ridgeback's COVID-19 Antiviral Shows Rapid Elimination Of Infectious SARS-CoV-2 Than Placebo

Merck - Ridgeback's COVID-19 Antiviral Shows Rapid Elimination Of Infectious SARS-CoV-2 Than Placebo

Merck & Co Inc (NYSE: MRK) and Ridgeback Biotherapeutics will present data evaluating Lagevrio (molnupiravir), an oral COVID-19 antiviral, at the 2022 European Congress of Clinical Microbiology & Infectious Diseases.

Get all your
news in one place.

100’s of premium titles.
One news app.

FDA Pushes Merck's Pneumococcal Vaccine Decision Date Into July For Expanded Use In Kids

The FDA has extended the Prescription Drug User Fee Act (PDUFA) date of the supplemental marketing application for Merck & Co Inc's (NYSE: MRK) pneumococcal 15-valent conjugate vaccine

The Daily Biotech Pulse: SELLA In-licenses Oncology Asset, Merck's Pneumococcal Vaccine Review Extended, Arc Biopharma COVID Drug Flunks Mid-Stage Study

Here's a roundup of top developments in the biotech space over the last 24 hours.

CNBC's Final Trades: Merck, Royal Caribbean Cruises And This Energy Play

On CNBC’s “Halftime Report Final Trades,” Jon Najarian said there was “unusual activity” in Royal Caribbean Cruises Ltd (NYSE: RCL). “I bought that,” he added.

The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall

Here's a roundup of top developments in the biotech space over the last 24 hours:

Get all your
news in one place.

100’s of premium titles.
One news app.

The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia

Here's a roundup of top developments in the biotech space over the last 24 hours:

EMA's Advisory Group Backs Approval For Merck's Keytruda In Various Cancer Settings

The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval of Merck & Co Inc (NYSE: MRK) for

The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO

Here's a roundup of top developments in the biotech space over the last 24 hours.

Investors Business Daily

How Rivals Merck, Bristol Myers Benefit From Eli Lilly's FDA Snag

The Food and Drug Administration on Thursday rejected a lung cancer drug Eli Lilly tested only in China, but LLY stock inched higher.

Merck Continues to See Executive Exodus; Here's A Look At All Recent Departures

Executive churn at pharma giant Merck & Co., Inc. (NYSE: MRK) has increased in recent times, so much so that it has caused stakeholders to sit up and take notice.

FDA Approves Second Indication For Merck's Keytruda In Endometrial Cancer

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout

Here's a roundup of top developments in the biotech space over the last 24 hours:

1 … 20 21 22 23

People

Mark Zuckerberg

Solita Marcelli

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Intel Corporation

Berkshire Hathaway

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

249,689 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play